IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study

Autor: Caspar da Cunha-Bang, Klaus Rostgaard, Carsten Utoft Niemann, Gudrun Jakubsdottir Egholm, Emelie Curovic Rotbain, Christian Bjørn Poulsen, Banafsheh Zahedi, Lisbeth Enggard, Henrik Hjalgrim, Henrik Frederiksen

Publikováno v: Haematologica
Rotbain, E C, Frederiksen, H, Hjalgrim, H, Rostgaard, K, Egholm, G J, Zahedi, B, Poulsen, C B, Enggard, L, Da Cunha-Bang, C & Niemann, C U 2020, ' IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment : A danish nationwide population-based study ', Haematologica, vol. 105, no. 6, pp. 1621-1629 . https://doi.org/10.3324/haematol.2019.220194
Rotbain, E C, Frederiksen, H, Hjalgrim, H, Rostgaard, K, Egholm, G J, Zahedi, B, Poulsen, C B, Enggard, L, da Cunha-Bang, C & Niemann, C U 2020, ' IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment : a Danish nationwide population-based study ', Haematologica, vol. 105, no. 6, pp. 1621-1629 . https://doi.org/10.3324/haematol.2019.220194

Patients with chronic lymphocytic leukemia and unmutated immunoglobulin heavy-chain variable region gene (IGHV) have inferior survival from time of treatment in clinical studies. We assessed real-world outcomes based on mutational status and treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3363cecd5df40ad4f0e65346cce8f0e2
https://pubmed.ncbi.nlm.nih.gov/31582540